These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 368786)

  • 1. Enhanced prostacyclin availability of blood vessels in uraemic humans and rats.
    Leithner C; Winter M; Silbauer K; Wagner O; Pinggera W; Sinzinger H
    Proc Eur Dial Transplant Assoc; 1978; 15():418-23. PubMed ID: 368786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular factors in the pathogenesis of uraemic bleeding.
    Remuzzi G; Bertani T; Livio M; Cavenaghi AE; Mysliwiec M; Marchesi D; Donati MC; de Gaetano G; Mecca G
    Proc Eur Dial Transplant Assoc; 1978; 15():449-55. PubMed ID: 368787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding in renal failure: a possible role of vascular prostacyclin (PGI2).
    Remuzzi G; Marchesi D; Cavenaghi AE; Livio M; Donati MB; de Gaetano G; Mecca G
    Clin Nephrol; 1979 Sep; 12(3):127-31. PubMed ID: 389502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of "prostacyclin-like" activity in the rat blood vessel: changes in prostacyclin production related to body weight.
    Horváth G; Benkö G
    Acta Physiol Hung; 1984; 63(1):21-7. PubMed ID: 6430032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of prostacyclin in blood vessels.
    Wong PY; Sun FF; McGiff JC
    J Biol Chem; 1978 Aug; 253(16):5555-7. PubMed ID: 27516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostacyclin as a protective factor for blood vessels].
    Leithner C; Sinzinger H; Silberbauer K
    Fortschr Med; 1980 Dec; 98(47-48):1845-9. PubMed ID: 7011923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular substances that modulate blood-to-vessel interactions.
    Ts'ao CH
    Artery; 1979 Mar; 5(3):246-61. PubMed ID: 393210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Age dependence of vascular prostacyclin formation in man (author's transl)].
    Leithner C; Sinzinger H; Schernthaner G; Silberbauer K; Klein K
    Aktuelle Gerontol; 1980 Sep; 10(9):387-9. PubMed ID: 6110374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin.
    Weksler BB
    Prog Hemost Thromb; 1982; 6():113-38. PubMed ID: 6762610
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostacyclin: its biosynthesis, actions, and clinical potential.
    Dusting GJ; Moncada S; Vane JR
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():59-106. PubMed ID: 6216790
    [No Abstract]   [Full Text] [Related]  

  • 12. Verapamil and the synthesis of prostacyclin in human veins.
    Fahr A; Langer R; Sziegoleit W; Blauschmidt J; Albert H; Liebal H; Mest HJ
    Pharmazie; 1991 Mar; 46(3):213-4. PubMed ID: 1881946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of a platelet component to endothelial prostacyclin production despite inhibition of platelet cyclooxygenase activity.
    Czervionke RL; Hoak JC; Haycraft DL; Fry GL; Mann KG
    Trans Assoc Am Physicians; 1982; 95():272-9. PubMed ID: 6820742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells.
    Curwen KD; Gimbrone MA; Handin RI
    Lab Invest; 1980 Mar; 42(3):366-74. PubMed ID: 6244462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
    Ubatuba FB; Moncada S; Vane JR
    Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced platelet accumulation onto injured carotid arteries in rabbits after aspirin treatment.
    Buchanan MR; Dejana E; Gent M; Mustard JF; Hirsch J
    J Clin Invest; 1981 Feb; 67(2):503-8. PubMed ID: 7007438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular prostacyclin release and metabolic derangement in diabetes.
    Harrison HE; Johnson M
    Horm Metab Res Suppl; 1981; 11():43-9. PubMed ID: 7033096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue.
    Matzky R; Darius H; Schrör K
    Arzneimittelforschung; 1982; 32(10):1315-8. PubMed ID: 6817760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin activity in rat kidney stimulated by angiotensin II.
    Silberbauer K; Sinzinger H; Winter M
    Br J Exp Pathol; 1979 Feb; 60(1):38-44. PubMed ID: 380621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.